Table 2.
Association of nodal status, tumor size, and grade with cumulative risk of breast cancer-specific mortality and non-breast cancer-specific mortality from years 5 to 20
| BCSM | Non-BCSM | |
|---|---|---|
| Cumulative risk (%) | Cumulative risk (%) | |
| y 5–20 | y 5–20 | |
| Nodal status | ||
| HR + | ||
| N0 | 9.9 | 32.2 |
| N1 | 21.9 | 26.5 |
| N2 | 38 | 26.5 |
| HR− | ||
| N0 | 7.9 | 23.2 |
| N1 | 12.2 | 19.7 |
| N2 | 19.9 | 22.6 |
| Tumor size among N0 only | ||
| HR + | ||
| T1a | 4.6 | 29.5 |
| T1b | 5.9 | 32.9 |
| T1c | 10.1 | 31.6 |
| T2 | 16.8 | 33.8 |
| HR− | ||
| T1a | 6.1 | 24.3 |
| T1b | 6.8 | 26.6 |
| T1c | 8.1 | 22.8 |
| T2 | 8.4 | 21.9 |
| Tumor grade among N0 only | ||
| HR + | ||
| Grade I | 5.7 | 32.6 |
| Grade II | 9.9 | 32.3 |
| Grade III/IV | 13.5 | 29.2 |
| HR− | ||
| Grade I | 6.6 | 32.2 |
| Grade II | 10.8 | 29.6 |
| Grade III/IV | 6.9 | 19.8 |
BCSM breast cancer-specific mortality, HR− hormone receptor negative, HR + hormone receptor positive, y years